MedTrace Logo

Target Engagement and Response to Oxytocin

NCT03245437 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-03-21

No results posted yet for this study

Summary

This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.

Conditions

Interventions

DRUG

Oxytocin nasal spray

nasal spray

BEHAVIORAL

Social Cognition Skills Training

Group based training in social cognition skills

BEHAVIORAL

Health Management

Group-based training in mental health management

DRUG

Placebo nasal spray

placebo condition

Sponsors & Collaborators

Principal Investigators

  • Stephen Marder, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-04
Primary Completion
2024-07-31
Completion
2024-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245437 on ClinicalTrials.gov